MannKind Corporation (NASDAQ:MNKD) together with Bella & Elle Media LLC reported sponsorship of “Reversed.” It is a production series targeted at educating the show’s members and audience about the adverse impact of poorly managed diabetes on lives. This much hyped series will air on Discovery Life Channel this summer.
Diabetes Advocate and Celebrity Chef, Charles Mattocks has created the show. Moreover, the bestselling author and award-winning producer will host “Reversed,” as it throws light on the lives of people affected by diabetes and the problems faced in course of not only changing their diet, but also in changing in mindset and planning for the exercise to combat the disease. “Reversed” will showcase experts including endocrinologists, diabetes educators, nutritionists, trainers, celebrity guests and therapists.
Charles Mattocks, who is the nephew of Bob Marley, stated that his uncle is known for his music across the world and now his vision is to help the people suffering from diabetes. ‘Reversed’ is more about transforming the behavior of people suffering with diabetes. They are thrilled that MannKind has agreed to become a part of mission.
Michael Castagna, the Chief Commercial Officer of MannKind, reported that the company is continually looking for platforms to enhance awareness around the opportunities, challenges and success patients living with diabetes witness on a regular basis. Mattock’s educational platforms showcase the determination and strength of people fighting to turn their lives better as they combat diabetes. They are thrilled to be associated with Mattock’s continuing measures to educate the public.
MannKind main focus has always remained on the discovery and development of therapeutic products for major diseases like diabetes. In the last trading session, the stock price of MannKind jumped more than 9% to close the session at $1.38. The gains came at a share volume of 2.26 million compared to average share volume of 1.96 million.
This report is for information purposes only, and is neither a solicitation or recommendation to buy nor an offer to sell securities. Financials Trend is not-a-registered-investment-advisor. Financials Trend is not a broker-dealer. Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. Financials Trend accepts no liability for any losses arising from an investor's reliance on the use of this material. Financials Trend sometimes gets compensated up to one hundred and fifty thousand dollars per month for featuring particular stocks. See site disclaimer for complete compensation. Financials Trend and its affiliates or officers currently hold no shares of these stocks. Financials Trend and its affiliates or officers will purchase and sell shares of common stock of these stocks, in the open market at any time without notice. Financials Trend will not update its purchases and sales of these stocks in any future postings on Financials Trend's websites. Certain information included herein is forward-looking within the context of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. The words "may", "would," "will," "expect," "estimate," "anticipate," "believe," "intend," " project," and similar expressions and variations thereof are intended to identify for ward-looking statements. Such forward- looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. *Financials Trend does not set price targets on securities. Never invest into a stock discussed on this web site or in this email alert unless you can afford to lose your entire investment.